IL36A and psoriasis: Il36a was required for the development of IMQ-induced murine psoriasis, whereas deletion of Il36a resulted in significant improvement in the skin lesions (65, 66); however, deficiency of Il36b or Il36g had no impact on reducing disease severity (66).